Immunovant (IMVT) Stock Chart & Stock Price History $15.24 +0.40 (+2.70%) Closing price 04:00 PM EasternExtended Trading$15.26 +0.02 (+0.10%) As of 06:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Immunovant Stock Price Performance The Immunovant (IMVT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 51.46%, with a year-to-date return of -38.47%. In the past month, the stock has decreased 15.05%, reflecting recent market activity. As of the latest close, Immunovant traded at $14.84 with a market cap of $2.59 billion and volume of 1.10 million shares. Five years ago, the stock traded at $32.59, representing a 53.24% decrease over that period. At the time, it had a market cap of $2.67 billion and a volume of 361,500 shares. Receive IMVT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Immunovant and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.13%1 Month Performance-15.05%3 Month Performance+4.67%Year-To-Date Performance-38.47%1 Year Performance-51.46%5 Year Performance-53.24% IMVT Stock Chart for Friday, August, 22, 2025 IMVT Chart by TradingView Immunovant Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/21/2025$14.82$14.84+0.13%$14.89$14.551.10 million shs$2.59 billion08/20/2025$14.82$14.82$14.99$14.501.56 million shs$2.58 billion08/19/2025$15.26$14.82-2.88%$15.24$14.791.14 million shs$2.58 billion08/18/2025$15.22$15.26+0.26%$15.52$15.171.06 million shs$2.66 billion08/15/2025$15.20$15.22+0.13%$15.31$14.981.78 million shs$2.65 billion08/14/2025$15.89$15.20-4.34%$15.76$15.141.05 million shs$2.65 billion08/13/2025$15.21$15.89+4.47%$16.18$15.141.05 million shs$2.72 billion08/12/2025$14.76$15.21+3.05%$15.42$14.851.37 million shs$2.60 billion08/11/2025$15.46$14.76-4.53%$15.60$14.321.69 million shs$2.52 billion08/08/2025$15.73$15.46-1.72%$16.08$15.16646,798 shs$2.64 billion Get the Latest News and Ratings for IMVT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immunovant and its competitors with MarketBeat's FREE daily newsletter. 08/07/2025$15.96$15.73-1.44%$16.43$15.54688,303 shs$2.69 billion08/06/2025$16.51$15.96-3.33%$16.48$15.58806,016 shs$2.73 billion08/05/2025$16.09$16.51+2.61%$16.56$15.641.21 million shs$2.82 billion08/04/2025$15.71$16.09+2.42%$16.11$15.49716,034 shs$2.75 billion08/01/2025$16.08$15.71-2.30%$16.03$15.371.53 million shs$2.69 billion07/31/2025$16.62$16.08-3.25%$16.67$15.841.13 million shs$2.75 billion07/30/2025$16.65$16.62-0.18%$17.12$16.331.09 million shs$2.84 billion07/29/2025$16.76$16.65-0.66%$16.82$16.461.27 million shs$2.85 billion07/28/2025$16.95$16.76-1.12%$17.49$16.621.57 million shs$2.87 billion07/25/2025$18.32$16.95-7.48%$17.31$15.314.51 million shs$2.90 billion07/24/2025$18.39$18.32-0.38%$18.64$18.011.21 million shs$3.13 billion07/23/2025$17.94$18.39+2.51%$18.89$18.021.44 million shs$3.15 billion07/22/2025$17.70$17.94+1.36%$18.09$17.78924,629 shs$3.07 billion07/21/2025$17.91$17.70-1.17%$18.32$17.48701,154 shs$3.03 billion Related Companies SLNO Stock Chart MRNA Stock Chart VRNA Stock Chart BBIO Stock Chart BPMC Stock Chart ELAN Stock Chart ROIV Stock Chart GRFS Stock Chart LEGN Stock Chart RVMD Stock Chart Receive IMVT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Immunovant and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IMVT) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunovant, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Immunovant With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access